Avalon says the partnership could help it become a leader in cellular medicines
Showing 25 of 1849
The Swiss university's GM-CSF protein neutralization technology was shown to mitigate graft-versus-host without stifling the positive effects of leukemia treatment
The Europe-focused investment firm is backed by The Supreme Cannabis Company Inc (TSE:FIRE), the $500mln Toronto-listed seed-to-consumer business
Memorial Sloan Kettering Cancer Center in New York will investigate the potential use of Kazia’s investigational new drug, GDC-0084.
Orphan designation is given to treatments for life-threatening conditions that affect fewer than 1 in 10,000 people
An independent research group, which conducted the survey on behalf of BevCanna, polled over 2,000 adults of legal drinking age in the US and Canada
The two licensed cannabis producers are Agro-Greens Natural Products Ltd and PureSinse Inc, a subsidiary of Pure Global Cannabis Inc
"We have improved the company's foundations to build the world's most customer-focused cannabis marketplace", said CEO Meni Morim, interim CEO of Namaste
In an exclusive interview with Proactive, Namaste's interim CEO Meni Morim outlines his plans going forward after a challenging half-year and says the firm is much better-positioned
The company is partnering with Shanghai Fosun Long March Medical Science Co Ltd, a manufacturer of diagnostic and laboratory instruments on a lung cancer study
The company is working with the Team Sanfilippo Foundation on a Phase 2b/3 study
Puzder joined the cannabis-focused healthcare company in January, when he was named to its board of directors
The money will fund a Phase 2b/3 study for patients with Sanfilippo syndrome types A and B
CEO James Nathanielsz says the company is planning a first-in-human study by undertaking “full scale manufacturing” of PRP for human use
The new antibody discovery collaboration with Entos Pharmaceuticals will use ImmunoPrecise's B cell Select platform in developing a therapeutic candidate to fight cancer
The study of AVA-001 is being conducted at the Hebei Yanda Lu Daopei Hospital and Beijing Lu Daopei Hospital in China
A phase-one clinical trial in 30 patients with advanced tumours is expected to start in 2020 across a number of US cancer centres.
The agreement allows the Namaste MD application to act as a direct-connect platform to enable patients to immediately transition from clinical consultation to connect with a medical professional
The grant will support a specific project to be conducted in collaboration with GIGA at the University of Liege, Belgium
HC Wainwright & Co set a price target of US$6, while Aegis Capital put it at US$3 on the pharmaceutical company
The drug-maker saw revenue jump to $12.7 million, up from $2.1 million in the prior-year quarter
Dr Sacha will explore the company’s flagship leronlimab drug as a potential therapy for HIV pre-exposure prophylaxis and HIV cure
CEO Tom Equels says Ampligen on a standalone basis has demonstrated effects in 'a number of solid tumors'
CEO Mark Emalfarb says Dyadic will have access to VTT’s patented genetic tools and their ‘substantial cell engineering expertise’
The European Investment Bank is evolving with rapidly progressing lithium-ion battery technology and reviewing its lending policy to include more battery raw materials and mining projects.